Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

G Fred Weiss


  • Director at Osmotica Pharmaceuticals Plc (OSMT), 2019-06-19
  • Director at Allergan Plc (AGN), 2018-05-04
  • Director at Actavis Inc. (ACT), 2013-10-03
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ACT $164.15 3,000 Director 24,275 2013-11-14 Filing
WPI $78.78 30,000 Director 25,398 2012-07-30 Filing
WPI $51.00 8,952 Director 19,334 2010-12-15 Filing
WPI $51.01 9,010 Director 28,286 2010-12-15 Filing
WPI $51.02 4,210 Director 37,296 2010-12-15 Filing